Diagnostics

New technologies and risk mitigation strategies to detect, prevent and remediate viral contaminations in raw materials, cell culture processes and facilities throughout the entire supply chain.

AsiaTIDES continues to be the premier forum to get a comprehensive update, meet key players and increase your knowledge of the oligonucleotide- and peptide-based therapeutics fields. The best forum to gain applied and basic knowledge, build your collaborative network, and learn skills to move your projects forward in one of today’s hottest research areas.

IBC's Bioprocess Training Academy course are two-day training sessions that allow you to gain new insight, evaluate industry standard practices and make new contacts in your field.

TIDES® remains THE place to meet all the important players in oligonucleotide and peptide therapeutics and diagnostic development and manufacturing, as well as raw material and equipment supply - and now discovery too.

Navigate FDA's evolving regulatory requirements to successfully achieve market approval or clearance for novel molecular technologies. Understand the latest developments in personalized medicine and companion diagnostics, and how new technologies including next generation sequencing will transform molecular diagnostics. Update your knowledge on analytical methods and validation.

IBC's Cell Line Development & Engineering conference will deliver the latest applications of automated tools, 'omics technologies, analytical methods and engineering strategies to help increase understanding and improve the stability, quality and manufacturability of your cell lines.

IBC's Drug & Diagnostic Development 2012 highlights innovations in antibody drug development, enabling genomic technologies and clinical biomarker strategies that are translating a better understanding of disease biology into clinical applications, leading to new therapeutics and diagnostics for cancer and other diseases.